You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ureter Cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Breast Adenocarcinoma, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Bronx (Rebastinib,

Terminated
  • Breast Cancer
  • +4 more
  • Bronx, New York
    Montefiore Medical Center
Mar 23, 2022

Endocervical Cancer Trial in Little Rock (The Oculus Quest 2 Virtual Reality Headset)

Not yet recruiting
  • Endocervical Cancer
  • The Oculus Quest 2 Virtual Reality Headset
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Jul 1, 2022

Solid Tumor Trial in Yantai (NK combined with Chemotherapy, Chemotherapy)

Recruiting
  • Solid Tumor
  • Yantai, Shandong, China
    Yantai Yuhuangding Hospital
Feb 7, 2022

Measuring Sleep Disturbance Among Cancer Patients

Completed
  • Advanced Cancer
  • Questionnaire
  • Actigraph
  • Houston, Texas
  • +1 more
Jul 12, 2022

Breast Cancer, Radiotherapy Side Effect Trial in Graz (Simultaneous integrated boost)

Withdrawn
  • Breast Cancer
  • Radiotherapy Side Effect
  • Simultaneous integrated boost
  • Graz, Austria
    Medical University of Graz
Oct 7, 2022

Breast Cancer Trial in Canada, Ireland, United States (Letrozole, Placebo)

Active, not recruiting
Has Results
  • Breast Cancer
  • Anniston, Alabama
  • +805 more
Oct 4, 2021

Locally Advanced Cervical Cancer Trial in Chongqing (Concurrent chemoradiation, Open/minimally invasive para-aortic lymph node

Not yet recruiting
  • Locally Advanced Cervical Cancer
  • Concurrent chemoradiation
  • Open/minimally invasive para-aortic lymph node dissection followed by concurrent chemoradiation
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
May 12, 2022

Esophageal Cancer, Gastric Cancer Trial in Strasbourg (Near Infra-Red Fluorescence Guided Surgery)

Recruiting
  • Esophageal Cancer
  • Gastric Cancer
  • Near Infra-Red Fluorescence Guided Surgery
  • Strasbourg, France
    Service de Chirurgie Digestive et Endocrinienne, NHC
Mar 28, 2022

Tumors Trial in France (Passation of neuropsychological test)

Recruiting
  • Neoplasms
  • Passation of neuropsychological test
  • Caen, France
  • +5 more
Mar 28, 2022

Lung Cancer Trial in Chandigarh (Low-dose computed tomography of chest)

Completed
  • Lung Cancer
  • Low-dose computed tomography of chest
  • Chandigarh, India
    Postgraduate Institute of Medical Education and Research (PGIMER
Mar 26, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

NSCLC Stage I Trial in Shanghai (traditional Chinese medicine and ablation in the primary tumor sites, ablation)

Recruiting
  • Non-small Cell Lung Cancer Stage I
  • traditional Chinese medicine and ablation in the primary tumor sites
  • ablation
  • Shanghai, Shanghai, China
    Shanghai 10th People's Hospital
Oct 27, 2021

Mantle Cell Lymphoma Trial in Atlanta (Ixazomib, Rituximab)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Atlanta, Georgia
  • +1 more
Oct 26, 2021

Prostate Cancer, Renal Cancer, Urethral Cancer Trial in San Francisco (Copper-64 labeled Granzyme B (64Cu-GRIP B), Positron

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Copper-64 labeled Granzyme B (64Cu-GRIP B)
  • Positron Emission Tomography (PET)
  • San Francisco, California
    University of California, San Francisco
Jun 7, 2023

Pancreatic Tumors Trial in Beijing, Nanjing, Shanghai (QingyiHuaji optimized formula)

Recruiting
  • Pancreatic Neoplasms
  • QingyiHuaji optimized formula
  • Beijing, Beijing, China
  • +3 more
Apr 22, 2023

Rectal Cancer Trial in Wiener Neustadt, Linz, Vienna (Chemoradiotherapy, Ipilimumab, Nivolumab)

Recruiting
  • Rectal Cancer
  • Chemoradiotherapy
  • +2 more
  • Wiener Neustadt, Lower Austria, Austria
  • +4 more
Mar 26, 2022

Castration Resistant Metastatic Prostate Cancer Trial in Baltimore (Testosterone cypionate, Enzalutamide, Testosterone

Recruiting
  • Castration Resistant Metastatic Prostate Cancer
  • Testosterone cypionate
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Aug 4, 2022

HPV, Throat Cancer, Oropharyngeal Carcinoma Trial in United States (diagnostic test, radiation, drug)

Recruiting
  • HPV
  • +4 more
  • 18 F-FMISO PET/CT
  • +4 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 4, 2022

Breast Cancer Trial in Shanghai (Hypofractionated radiotherapy, Conventional radiotherapy)

Recruiting
  • Breast Cancer
  • Hypofractionated radiotherapy
  • Conventional radiotherapy
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
May 29, 2022

Breast Cancer, Metastatic Breast Cancer Trial in Caen, Rouen (Blood sampling)

Recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • Blood sampling
  • Caen, France
  • +1 more
May 27, 2022

Advanced Breast Cancer Trial in Changsha (TQB3909 tablets)

Recruiting
  • Advanced Breast Cancer
  • TQB3909 tablets
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Mar 16, 2023

Lymphovascular Propagation in Treatment of Endometrial Cancer

Completed
  • Endometrial Cancer
  • LVSI
  • hysterectomy
  • Banská Bystrica, Slovakia
    F.D. Roosevelt Teaching Hospital with Policlinic
Feb 19, 2022

Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

Active, not recruiting
Has Results
  • Solid Tumor
  • Medullary Thyroid Cancer
  • Guangzhou, Guangdong, China
  • +12 more
May 9, 2022

Breast Tumors, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor Trial in Baku (68Ga-FAPI-46 PET/CT)

Recruiting
  • Breast Neoplasms
  • +3 more
  • 68Ga-FAPI-46 PET/CT
  • Baku, Azerbaijan
    National Centre of Oncology
Jun 21, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Houston

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Ipilimumab
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022